Managers

Binance becomes latest crypto company to launch venture fund

Floodgate's Mike Maples on building software-defined networks

Romulus pulls in $15 mln for third fund

Romulus Capital has raised $15 million for its third fund, according to an SEC filing. No target was listed on the document. Boston-based Romulus Capital is an early-stage venture firm focused on tech companies.

Cancer drug developer Xynomic Pharma scores funding

Dover, Delaware and Shanghai-based Xynomic Pharma, a cancer drug developer, has raised an undisclosed amount of financing. Northern Light Venture Capital, Zhongshan Bison Healthcare Investment Limited and Hakim Unique Internet Company Limited led the round with participation from other investors that included Prosperico Ventures.

Hedge fund Translunar One partners with Sterling Global to offer digital asset custody, attract LPs

SV Angel to scale back operations, not raise new fund

TCV, Battery, Summit head up emerging portfolio at Nevada pension

Cortexyme racks up $76 mln Series B

South San Francisco-based Cortexyme Inc, a developer of drugs focused on treating Alzheimer’s disease and other degenerative diseases, has closed $76 million in Series B funding. The investors included Sequoia Capital, Vulcan Capital, Verily Life Sciences, EPIQ Capital Group, RSL Investments, Huizenga Capital, Pfizer, Takeda Ventures, Lamond Family, Breakout Ventures and Dolby Family Ventures.

Modern Fertility nets $6 mln

Modern Fertility, a woman's health company, has raised $6 million in funding. Maveron and Union Square Ventures led the round with participation from other investors that included Sound Ventures and SV Angel.

WelCan Capital rolls out cannabis-focused initial impact investment fund

WelCan Capital, a cannabis-focused venture firm, has launched its debut impact investment fund. No financial terms were disclosed. So far, the fund has invested in Sanctuary Medicinals, a Massachusetts based licensed operator and Treez, an enterprise SaaS platform for dispensaries.